Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study

MLA

Katrine Finderup Nielsen, et al. Vaccine Effectiveness against SARS-CoV-2 Reinfection during Periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) Dominance: A Danish Nationwide Study. June 2022. EBSCOhost, https://doi.org/10.1101/2022.06.01.22275858.

APA

Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, Michael Asger Andersen, Marianna Meaidi, Jan Wohlfahrt, & Palle Valentiner-Branth. (2022). Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study. https://doi.org/10.1101/2022.06.01.22275858

Chicago

Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, et al. 2022. “Vaccine Effectiveness against SARS-CoV-2 Reinfection during Periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) Dominance: A Danish Nationwide Study,” June. doi:10.1101/2022.06.01.22275858.